Company intelligence / Profile preview

Almo Pharma

New Delhi, Delhi, India

Ownership: Private
Development stage: Other

Overview

Almo Pharma appears to be a small, active pharmaceutical company in India focused on commercialized generic and branded-generic medicines rather than novel biotech R&D. Its website describes capabilities in drug development, manufacturing, and marketing, and lists marketed products spanning anti-infectives, gastrointestinal medicines, respiratory/allergy treatments, and digestive formulations. Visible products include amoxicillin + clavulanic acid, ofloxacin, montelukast + levocetirizine, rabeprazole + domperidone, colistin dry syrup, and digestive drops. Based on publicly visible information, the company looks like a domestic pharma marketer/supplier with a broad primary-care product portfolio and no clearly disclosed clinical-stage innovative pipeline.

Therapeutic areas: GastroenterologyImmunologyPulmonologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Almo Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Almo Pharma.

Explore the full profile